Niki BioSolutions, Inc.

Niki BioSolutions, Inc.

NIKI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$117.63K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Niki BioSolutions, Inc.Niki BioSolutions, Inc.-0.1--7217%-74.6
$0.14

Current Fair Value

91.5% downside

Overvalued by 91.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$117,629.00
Enterprise Value$1.79 Million
Earnings per Share$-19
Beta0.17
Outstanding Shares73,518

Return

Return on Equity-7216.56%ROE
Return on Assets-19.80%
Return on Invested Capital-14.44%

Valuation & Multiples

P/E Ratio-0.09P/E Ratio
PEG1.03PEG
Price to Sales-Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.98
Enterprise Value to Net Income-1
Total Debt to Enterprise1.96
Debt to Equity74.65Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Aptorum Group Ltd

1 employees
CEO: Chung Yuen Huen

Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its w...